08:00 , Nov 9, 2015 |  BC Week In Review  |  Company News

Advanomics, Sunshine Biopharma deal

Sunshine purchased U.S. Patent No. 8,236,935 from Advanomics, which owns about 23% of Sunshine. The patent covers all rights related to Sunshine’s Adva-27a in the U.S. Sunshine is planning a Phase I trial of...
07:00 , Sep 2, 2013 |  BC Week In Review  |  Company News

Advanomics, Sunshine Biopharma, Laboratoires Garmen Inc. deal

Sunshine said its Advanomics parent company will acquire Garmen for an undisclosed amount. Garmen will manufacture 1 kg of Adva-27a, the lead compound of Advanomics and Sunshine, which will be used to complete the...